Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
HotStart Universal 2X Green qPCR Master Mix: ISC Assays
2026-09-11
Build a reproducible dye-based qPCR workflow for testing how tunicamycin-induced endoplasmic reticulum stress affects intestinal stem-cell biology. This guide combines the HotStart Universal 2X Green qPCR Master Mix with melt curve verification, pathway-focused controls, and troubleshooting strategies for reliable gene expression quantification.
-
STUB1–TPIT Control of ACTH in Cushing Disease
2026-09-11
Liu et al. identify STUB1 as an E3 ubiquitin ligase that promotes TPIT degradation, reducing POMC transcription and ACTH secretion in corticotroph tumor models. The study also uses NanoBiT-based screening to nominate irbesartan and lumiracoxib as compounds that enhance STUB1–TPIT regulation, while highlighting important limitations before clinical translation.
-
HSP90 Regulation of RNA Foci in DM1
2026-09-10
Johnson and colleagues used an unbiased small-molecule RNA-FISH screen to identify HSP90 as a regulator of endogenous CUG-repeat RNA foci and DMPK mRNA in Myotonic Dystrophy type 1. The study further implicates p-STAT3 in undifferentiated myoblasts while showing that differentiation reverses the response, highlighting cell-state dependence as a critical variable for DM1 mechanism studies.
-
PD0325901: Reliable MEK Inhibition in Cell Assays
2026-09-10
This scenario-based guide explains how PD0325901 (SKU A3013) can improve interpretation of viability, proliferation, and cytotoxicity experiments through mechanistic MEK inhibition. It covers solvent compatibility, protocol handling, pathway-specific data interpretation, and practical product-selection criteria.
-
Rotigotine hydrochloride for Reliable Cell Assays
2026-09-09
This scenario-based guide explains how Rotigotine hydrochloride, SKU A3777, can support reproducible cell viability, neuroprotection, and Parkinson’s disease research workflows. It connects formulation, concentration selection, route-specific evidence, and practical vendor evaluation to help researchers interpret results with greater confidence.
-
Dietary Arachidonic Acid and Humoral Immunity
2026-09-09
The reference study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its central mechanistic contribution is the identification of a lymph-node arachidonic acid–PGI2–cAMP–PKA pathway that supports CD86 expression and AID activation during germinal-center B-cell responses.
-
Ceftazidime for Gram-Negative Resistance Research
2026-09-09
Ceftazidime provides a practical phenotypic tool for studying Gram-negative susceptibility, Pseudomonas aeruginosa infection models, and resistance-associated workflow decisions. This guide connects assay design with plasmid, carbapenemase, and transmission findings from recent Enterobacter cloacae surveillance.
-
HyperScript™ First-Strand cDNA Synthesis Kit
2026-09-08
This scenario-driven guide explains how upstream reverse-transcription variability can complicate cell viability, proliferation, and cytotoxicity assays. It evaluates primer choice, structured RNA, low-copy targets, interpretation of qPCR data, and vendor selection for HyperScript™ First-Strand cDNA Synthesis Kit (SKU K1072).
-
Bifidobacterium vs FMT in Chronic Hepatic Encephalopathy
2026-09-07
This study compares Bifidobacterium and fecal microbiota transplantation in a rat model of chronic hepatic encephalopathy using [18F]PBR146 micro-PET/CT imaging. Its main contribution is showing that regional, rather than global, neuroinflammation imaging may reveal treatment-related differences that are not captured consistently by behavior, cytokines, or whole-brain uptake.
-
ATG4B Nuclear Translocation and DNA Repair in AML
2026-09-07
The reference study identifies a mechanistic link between energy deficiency, ATG4B nuclear translocation, and impaired DNA repair in acute myeloid leukemia. It shows that nuclear ATG4B interferes with PRMT1-dependent MRE11 methylation, increasing genomic instability, while ATG4B inhibition reduces malignant progression in cellular and mouse AML models.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-09-05
The Protease Inhibitor Cocktail is an EDTA-free, 100X reagent for protein stability in plant extracts. Its six inhibitor classes support protein degradation inhibition before Western blotting, immunoprecipitation, kinase assays, and related workflows.
-
Dietary Arachidonic Acid Accelerates Humoral Immunity
2026-09-04
The reference study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node arachidonic acid–PGI2–cAMP–PKA pathway that supports CD86 expression and AID activation during germinal-center B-cell responses.
-
TMRE mitochondrial membrane potential assay kit Guide
2026-09-04
Build a controlled ΔΨm workflow for apoptosis, sodium-overload, and mitochondrial physiology studies with TMRE and CCCP validation. This practical guide connects mechanistic findings on sodium-driven energy failure with plate-based, imaging, and isolated-mitochondria assay designs.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-09-03
The reference study shows that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by preserving intestinal barrier function through an NR1I3–CDH1–E-cadherin regulatory pathway. Its combination of probiotic intervention, intestinal E-cadherin suppression, transcriptomic analysis, and in vitro validation moves the work beyond descriptive microbiome observations toward a testable epithelial mechanism.
-
Fucoidan: Mechanism-First Assay Design
2026-09-03
Fucoidan research benefits from a mechanism-first strategy that connects apoptosis, immune modulation, and membrane biology without overextending the evidence. This guide uses the CLCC1 herpesvirus nuclear-egress study to sharpen assay selection, controls, and translational interpretation.